CRB-65 predicts death from community-acquired pneumonia.
about
Advances in the prevention, management, and treatment of community-acquired pneumoniaFrequency of vital signs monitoring and its association with mortality among adults with severe sepsis admitted to a general medical ward in Uganda.Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study.Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI).Comparison of three predictive rules for assessing severity in elderly patients with CAP.Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZSerum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort studyPro-adrenomedullin usefulness in the management of children with community-acquired pneumonia, a preliminar prospective observational studyReducing uncertainty in managing respiratory tract infections in primary care.Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia.Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections.Pneumonia severity, comorbidity and 1-year mortality in predominantly older adults with community-acquired pneumonia: a cohort study.Severity assessment of lower respiratory tract infection in Malawi: derivation of a novel index (SWAT-Bp) which outperforms CRB-65.CURB-65 pneumonia severity assessment adapted for electronic decision support.Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium.Blood cultures taken from patients attending emergency departments in South Africa are an important antibiotic stewardship tool, which directly influences patient managementOutbreak of a beta-lactam resistant non-typeable Haemophilus influenzae sequence type 14 associated with severe clinical outcomes.Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort studyRole of Semi-quantitative Serum Procalcitonin in Assessing Prognosis of Community Acquired Bacterial Pneumonia Compared to PORT PSI, CURB-65 and CRB-65.Can Procalcitonin Add to the Prognostic Power of the Severity Scoring System in Adults with Pneumonia?Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention studyRecent changes in the management of community acquired pneumonia in adultsInpatient treatment of community-acquired pneumonias with integrative medicine.Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality.External validation of the CURSI criteria (confusion, urea, respiratory rate and shock index) in adults hospitalised for community-acquired pneumonia.Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: systematic review and meta-analysis.Management of community-acquired pneumonia: a review and update.Modern Management of Community-Acquired Pneumonia: Is It Cost-Effective and are Outcomes Acceptable?Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality.Elderly patients with community-acquired pneumonia: optimal treatment strategies.Predicting mortality with severity assessment tools in out-patients with community-acquired pneumonia.[CAPNETZ. The competence network for community-acquired pneumonia (CAP)].Precision medicine for the treatment of severe pneumonia in intensive care.New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality: A Validation and Clinical Decision-making Study.Prediction of Outcome From Adult Bacterial Meningitis in a High-HIV-Seroprevalence, Resource-Poor Setting Using the Malawi Adult Meningitis Score (MAMS).Comparing the APACHE II score and IBM-10 score for predicting mortality in patients with ventilator-associated pneumonia.CURB-65 Performance Among Admitted and Discharged Emergency Department Patients With Community-acquired Pneumonia.Systemic symptoms predict presence or development of severe sepsis and septic shock.
P2860
Q26753138-BCEDEC0F-EBF9-4A39-8FAB-24CF755EC462Q30414416-E1C2714B-EF7B-4707-B7FA-ECE1824BE54DQ33581932-BDA38B0A-2B2F-4F2B-81FB-F14F15426DD2Q33929402-EFA8B89F-AB73-41E6-BFA5-689C8C0736EFQ34032698-7F5EB8C7-77FF-44D7-A6DD-030DC8D4615BQ34164151-DB2CF3D9-CAD6-4330-9394-04083DA5C0CEQ34231948-983C4E08-4FED-4EE5-AEBB-19D52A25AB66Q34346628-622F4445-63C6-4784-BD82-01C9ED60606EQ34350110-58BEB78E-B02F-479E-B2FD-F0CFBE3544B6Q34419979-D7329E7B-00D1-4678-BB9D-AF4128968B73Q34773984-2C8A5FCC-9446-4BC6-93CC-F82ABEF23B83Q35007069-21784D17-A829-4B43-867E-808281CB79BCQ35064123-A7C121E0-6070-47C1-8413-B246F586A817Q35410821-7E8B7014-C66D-41F9-BC1B-DE9B646CC5A6Q35642397-5B4335FF-32ED-4BDD-B91B-17F8862872AFQ35799516-11453FF9-6409-40FA-888F-CBFB7A525A5DQ35877643-52348636-7703-47A7-8893-524808B0F634Q35996017-4B030EE0-D7B9-4C75-9F00-17E228723623Q36068141-A81BE22A-4A6A-4F71-AA69-01155902C523Q36238642-6D8544E0-7ADB-4E9B-B77F-DBAC9B392067Q36281234-E8709729-5659-4FB5-8DE0-FD82229AD915Q36496314-B1BB9C46-AB67-4567-9A27-7FE59186D7D2Q36728885-5D708567-0115-4093-9D80-098B3208A40DQ36907878-20EFC892-585B-4987-94C2-073AE14986A5Q37270551-9F1AEDD0-37BE-4D81-89B7-5B6363027A31Q37433579-E84603EE-8FA2-4A15-AA9E-8F423C735BC8Q37515038-F2494983-C072-4C93-A114-2E39AF060AF0Q37795128-34F3325E-A1F0-44B6-ABA0-BFC21A3D3A21Q37799174-34061D0A-0F8E-4A9D-A098-50D8F1B1EBA9Q37852638-8E6C219A-B965-44DB-A8E6-E69D58EBCE8EQ37870823-73D8130C-DB1B-4557-A8B8-A71633E175A2Q37896600-C8E412A9-7413-46A3-A54F-096A23C60C7AQ37902371-7071EAA4-8119-403F-90AF-1006B116340BQ38382078-A5E21AE2-9D2A-4730-8B52-2B56371EC833Q38704065-4E3DFDE9-E16F-443C-9BAB-CD86D371ECCEQ38725994-5A88C50F-3855-474E-8D23-FAEECAF4EE2FQ39121791-F96F169A-5DA6-4903-AE56-0E32066DAB14Q39289611-F6FFE169-DC93-460F-90CD-DBF6D5317D8BQ40042762-DEEA553B-A8E1-4165-BB9B-CB7674B0CF50Q40134239-BA768132-3DD4-4DAF-BE41-2879D4BCB02B
P2860
CRB-65 predicts death from community-acquired pneumonia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
CRB-65 predicts death from community-acquired pneumonia.
@en
CRB-65 predicts death from community-acquired pneumonia.
@nl
type
label
CRB-65 predicts death from community-acquired pneumonia.
@en
CRB-65 predicts death from community-acquired pneumonia.
@nl
prefLabel
CRB-65 predicts death from community-acquired pneumonia.
@en
CRB-65 predicts death from community-acquired pneumonia.
@nl
P2093
P1476
CRB-65 predicts death from community-acquired pneumonia.
@en
P2093
P304
P356
10.1111/J.1365-2796.2006.01657.X
P407
P577
2006-07-01T00:00:00Z